Rituxan vs. Tysabri

• Are Tysabri and Rituxan the Same Thing?
• What Are Possible Side Effects of Rituxan?
• What Are Possible Side Effects of Tysabri?
• What is Rituxan?
• What is Tysabri?
• What Drugs Interact with Rituxan?
• What Drugs Interact with Tysabri?
• How Should Rituxan Be Taken?
• How Should Tysabri Be Taken?

Rituxan(rituximab) andTysabri(natalizumab) aremonoclonalantibodies used to treatmultiple sclerosis(MS).

Rituxan is used off-label to treat MS.

Rituxan is also usedincombination with othercancermedicines to treat non-Hodgkin'slymphoma, and in combination with another drug calledmethotrexateto treat symptoms of adultrheumatoid arthritis.

Tysabri is also used to treat moderate to severeCrohn's disease在成人。其他Cr后Tysabri通常是给定的ohn'sdiseasemedications have been tried without successful treatment of thiscondition.

Commonside effectsof Rituxan include:

• headache,
• fever,
• chills,
• stomachpain,
• nausea,
• diarrhea,
• heartburn,
• flushing,
• night sweats,
• weakness,
• muscleorjointpain,
• back pain, or
• dizziness.

Tell yourdoctorif you experience serious side effects of Rituxan including:

• increased thirst or urination,
• swelling of the hands orfeet, or
• tingling of the hands or feet.

Common side effects of Tysabri include:

• headache,
• tiredfeeling,
• joint or muscle pain,
• redness or irritation at the injection site,
• swelling hands/feet/ankles,
• changes inmenstrual cycle,
• stomach pain,
• diarrhea,
• skinrash,
• depression,
• painfulmenstrual cramps, or
• cold symptoms such asstuffy nose, sneezing, orsore throat.

Tell your doctor if you have side effects while Tysabri is being given or shortly after your treatment is finished (infusion reaction) including:

• chills,
• fever,
• flushing,
• nausea,
• dizziness, and
• chest pain.

Rituxan (rituximab) is a cancermedicationused in combination with other cancer medicines to treat non-Hodgkin's lymphoma. Rituxan is also used in combination with another drug called methotrexate to treat symptoms of adult rheumatoidarthritis.

Tysabri (natalizumab) is amonoclonal antibodyused in to treat relapsing forms of multiplesclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this condition.

Rituxan may interact withcisplatin,adalimumab, auranofin,azathioprine,cyclosporine道,英夫利昔单抗,leflunomide,minocycline,sulfasalazine,blood pressuremedications, or medication to treatmalaria.

Tysabri may interact with other medicines, especially those that mayaffecttheimmune systemsuch as:interferon, cyclosporine,sirolimus, tacrolimus, basiliximab, efalizumab,muromonab-CD3,mycophenolatemofetil, azathioprine, leflunomide, etanercept, orchemotherapyorradiationtreatments.

Rituxan is administered under aphysician's supervision. The dose of Rituxan varies depending on the disorder being treated and the number of infusions (doses) needed.

The recommended dose of Tysabri for multiple sclerosis or Crohn's disease is 300mgintravenousinfusion over one hour every four weeks.